Your browser doesn't support javascript.
loading
The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus.
O'Donoghue, Michelle L; Kato, Eri T; Mosenzon, Ofri; Murphy, Sabina A; Cahn, Avivit; Herrera, Marisol; Tankova, Tsvetalina; Smahelová, Alena; Merlini, Piera; Gause-Nilsson, Ingrid; Langkilde, Anna Maria; McGuire, Darren K; Wilding, John P H; Leiter, Larry A; Bhatt, Deepak L; Raz, Itamar; Sabatine, Marc S; Wiviott, Stephen D.
Afiliação
  • O'Donoghue ML; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA. modonoghue@bwh.harvard.edu.
  • Kato ET; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Mosenzon O; Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel.
  • Murphy SA; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
  • Cahn A; Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel.
  • Herrera M; Torre Medica Providencia, Guadalajara, Mexico.
  • Tankova T; Department of Endocrinology, Medical University, Sofia, Bulgaria.
  • Smahelová A; Faculty Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Merlini P; 2nd Division of Cardiology, Ca' Granda Niguarda Hospital, Milan, Italy.
  • Gause-Nilsson I; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Langkilde AM; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center, and Parkland Health and Hospital System, Dallas, TX, USA.
  • Wilding JPH; Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.
  • Leiter LA; Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Bhatt DL; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
  • Raz I; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
  • Sabatine MS; Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel.
  • Wiviott SD; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Diabetologia ; 64(6): 1226-1234, 2021 06.
Article em En | MEDLINE | ID: mdl-33611623
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos